# Soluble VE-cadherin in Prediction and Diagnosis of Early Postoperative Hypoxemia After Cardiopulmonary Bypass

> **NCT05647382** · NA · COMPLETED · sponsor: **Zhuan Zhang** · enrollment: 100 (actual)

## Conditions studied

- Hypoxemia
- ARDS
- Lung Injury, Acute
- Cardiopulmonary Bypass

## Interventions

- **DIAGNOSTIC_TEST:** blood cell analysis, blood gas surveillance, chest radiograph and echocardiography

## Key facts

- **NCT ID:** NCT05647382
- **Lead sponsor:** Zhuan Zhang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647382, "Soluble VE-cadherin in Prediction and Diagnosis of Early Postoperative Hypoxemia After Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05647382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*